Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Apoptosis-inducing iminodiacetic acid derivatives described by Mitsui Toatsu

May 6, 1998

GenVec, Fuso collaborate on cancer gene therapies

May 6, 1998

FDA approves SuperGen's injectable mitomycin

May 6, 1998

New antitumor compounds from Ajinomoto

May 6, 1998

GenVec in-licenses rights to TNF-alpha for gene therapy applications

May 5, 1998

Phase I trial results presented for the antifolate LY-231514

May 5, 1998

Natural antitumor substances with broad-spectrum activity isolated by Banyu scientists

May 5, 1998

Antitumor agents of microbial origin discovered by Nippon Kayaku

May 5, 1998

Zeneca seeks new labeling for breast cancer therapy

May 5, 1998

FDA grants accelerated approval for Xeloda

May 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...